The MiningNewsWire Podcast

CNS Pharmaceuticals (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the Investigational New Drug (IND) application for its lead product candidate, Berubicin, for the treatment of Glioblastoma Multiforme (GBM) is now approved and in effect as filed with the US Food and Drug Administration (FDA). The Company will initiate its trial during the first quarter of 2021 to investigate the efficacy of Berubicin in adults with GBM who have failed first-line therapy.  Recent correspondence between the Company and the FDA resulted in modifications to the previously disclosed trial design, including designating overall survival (OS) as the primary endpoint of the study. OS is a rigorous endpoint that the FDA has recognized as a basis for approval of oncology drugs when a statistically significant improvement can be shown relative to a randomized control arm.

To view the original press release, visit https://nnw.fm/zWHqI

More than 700 million people worldwide are affected with some form of mental illness, addiction or eating disorder, representing about 13% of total disease burden. In reality, the worldwide picture is a bit murky, considering the high frequency of nondiagnosis as well as lack of treatment, even in the most developed countries. Advances in medicine to treat these conditions of the brain have been elusive, as conventional drugs that treat symptoms and not underlying causes remain the most popular. There are reasons to be optimistic about the future, though, underscored by increased research activity surrounding psychedelics. This is the area of focus for Cybin Inc. (NEO: CYBN) (Profile), which this week acquired Adelia Therapeutics, a transformational move that broadened addressable indications in its pipeline and strengthened its scientific team. Cybin has a three-pillar approach,  its initial sights set on treating major depression disorder (“MDD”) now expanded to address additional indication as well through innovative psychedelic therapeutics development and unique delivery technologies. Cybin stands shoulder-to-shoulder with peers striving for a world of better mental well-being such as COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine Inc (OTC: MMEDF) (NEO: MMED), Numinus Wellness Inc. (OTC: LKYSF) (NEO: NUMI) (TSX.V: NUMI) and HAVN Life Sciences (OTC: HAVLF), all of which are developing innovative approaches to bring new psychedelic-based therapies to patients in need.

The United States was once a thriving producer of rare earth elements (“REEs”), a group of 17 elements deemed critical to clean energy and modern technologies. REEs are used in a bevy of applications including cell phones, computers, electric vehicles, defense equipment, renewable energy systems and more. China has dominated global rare earth markets, driving out competitors and controlling nearly all of the world’s processing capacity. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world. Against this backdrop, the U.S. government is committed to ending its dependence upon China for REEs, and Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (Profile) is among the leaders with projects that intend to re-ignite REE production in the U.S., which in Energy Fuels’ case, is expected as soon as early 2021. In December 2020, the company advanced its entry into the REE market by inking a three-year supply agreement with the Chemours Company (NYSE: CC) to acquire a minimum of 2,500 tons per year of natural monazite sand ore, one of the highest-grade and highest-value rare earth minerals in the world. Yet, the relatively tiny quantity of natural monazite the company will be acquiring from Chemours contains close to 10% of total U.S. demand for rare earths. Chemours is the nation’s leading miner of monazite, a reddish-brown phosphate mineral sand containing high concentrations of REEs and uranium. Companies are looking to shift their supply chains away from China, as EV maker Tesla Inc. (NASDAQ: TSLA) recently did by becoming a lithium miner in Nevada to supplement its other material feeds. Tech juggernaut Apple Inc. (NASDAQ: AAPL) is following a different path, using recycled REEs in its latest products with plans for the entire corporate footprint to have net zero climate impact by 2030. Siemens Gamesa Renewable Energy SA (OTC: GCTAF) has challenges of its own as a major supplier of wind turbines, which requires REEs in their construction.

The COVID-19 pandemic has reached a benchmark in the United States, topping 15 million cases as the death count exceeds 285,000. The pandemic has transformed the world in many ways, including bringing digital technologies to the forefront of a socially distanced world. In this space, Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) (Profile) recently made history as the first-ever, end-to-end venue-tracing and management solution. A provider of contactless solutions and artificial intelligence aimed at driving automated marketing, venue management and tracing to the brick-and-mortar space, Loop gained national attention for its “bubble,” which allowed NCAA basketball to play on in Nevada and Florida. Pairing Loop Insights’ venue-tracing platform with revised safety protocol allowed games to be played at multiple venues without a single case of COVID-19 reported. Loop Insights, which calls ecommerce juggernaut Amazon.com Inc. (NASDAQ: AMZN) an investor and partner, joins majors such as The Walt Disney Co. (NYSE: DIS), one of the world’s largest producers of entertainment; Alphabet Inc. (NASDAQ: GOOGL), the parent company of tech behemoth Google; and cruise ship operator Carnival Corp. (NYSE: CCL) in the fight to get the economy back safely operating at full capacity while protecting guests, entertainers, and employees at the same time.

The COVID-19 pandemic has reached a benchmark in the United States, topping 15 million cases as the death count exceeds 285,000. The pandemic has transformed the world in many ways, including bringing digital technologies to the forefront of a socially distanced world. In this space, Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) (Profile) recently made history as the first-ever, end-to-end venue-tracing and management solution. A provider of contactless solutions and artificial intelligence aimed at driving automated marketing, venue management and tracing to the brick-and-mortar space, Loop gained national attention for its “bubble,” which allowed NCAA basketball to play on in Nevada and Florida. Pairing Loop Insights’ venue-tracing platform with revised safety protocol allowed games to be played at multiple venues without a single case of COVID-19 reported. Loop Insights, which calls ecommerce juggernaut Amazon.com Inc. (NASDAQ: AMZN) an investor and partner, joins majors such as The Walt Disney Co. (NYSE: DIS), one of the world’s largest producers of entertainment; Alphabet Inc. (NASDAQ: GOOGL), the parent company of tech behemoth Google; and cruise ship operator Carnival Corp. (NYSE: CCL) in the fight to get the economy back safely operating at full capacity while protecting guests, entertainers, and employees at the same time.

The United States was once a thriving producer of rare earth elements (“REEs”), a group of 17 elements deemed critical to clean energy and modern technologies. REEs are used in a bevy of applications including cell phones, computers, electric vehicles, defense equipment, renewable energy systems and more. China has dominated global rare earth markets, driving out competitors and controlling nearly all of the world’s processing capacity. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world. Against this backdrop, the U.S. government is committed to ending its dependence upon China for REEs, and Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (Profile) is among the leaders with projects that intend to re-ignite REE production in the U.S., which in Energy Fuels’ case, is expected as soon as early 2021. In December 2020, the company advanced its entry into the REE market by inking a three-year supply agreement with the Chemours Company (NYSE: CC) to acquire a minimum of 2,500 tons per year of natural monazite sand ore, one of the highest-grade and highest-value rare earth minerals in the world. Yet, the relatively tiny quantity of natural monazite the company will be acquiring from Chemours contains close to 10% of total U.S. demand for rare earths. Chemours is the nation’s leading miner of monazite, a reddish-brown phosphate mineral sand containing high concentrations of REEs and uranium. Companies are looking to shift their supply chains away from China, as EV maker Tesla Inc. (NASDAQ: TSLA) recently did by becoming a lithium miner in Nevada to supplement its other material feeds. Tech juggernaut Apple Inc. (NASDAQ: AAPL) is following a different path, using recycled REEs in its latest products with plans for the entire corporate footprint to have net zero climate impact by 2030. Siemens Gamesa Renewable Energy SA (OTC: GCTAF) has challenges of its own as a major supplier of wind turbines, which requires REEs in their construction.

More than 700 million people worldwide are affected with some form of mental illness, addiction or eating disorder, representing about 13% of total disease burden. In reality, the worldwide picture is a bit murky, considering the high frequency of nondiagnosis as well as lack of treatment, even in the most developed countries. Advances in medicine to treat these conditions of the brain have been elusive, as conventional drugs that treat symptoms and not underlying causes remain the most popular. There are reasons to be optimistic about the future, though, underscored by increased research activity surrounding psychedelics. This is the area of focus for Cybin Inc. (NEO: CYBN) (Profile), which this week acquired Adelia Therapeutics, a transformational move that broadened addressable indications in its pipeline and strengthened its scientific team. Cybin has a three-pillar approach,  its initial sights set on treating major depression disorder (“MDD”) now expanded to address additional indication as well through innovative psychedelic therapeutics development and unique delivery technologies. Cybin stands shoulder-to-shoulder with peers striving for a world of better mental well-being such as COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine Inc (OTC: MMEDF) (NEO: MMED), Numinus Wellness Inc. (OTC: LKYSF) (NEO: NUMI) (TSX.V: NUMI) and HAVN Life Sciences (OTC: HAVLF), all of which are developing innovative approaches to bring new psychedelic-based therapies to patients in need.

On election day this year, four more states voted to legalize the recreational use of cannabis, bringing the total of states that now allow recreational cannabis use to 15. This growing acceptance of cannabis, and more specifically CBD, which is now legal in all 50 states, has sparked an explosion of new CBD-infused products and brands within the consumer packaged goods (“CPG”) space. Estimates about how large the legalized cannabis market may grow vary widely, but a Lido Consulting report notes that the total addressable cannabis market (“TAM”) could potentially hit $1 trillion in global economic impact by 2027. Seeing almost unlimited potential, companies are rushing to take advantage of the massive opportunity. Continuing its aggressive growth strategy, The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) (Profile) entered the CBD space with the launch of its A88CBD(TM) brand. Already nationally recognized for its premium bottled water and flavor-infused water,  Alkaline Water now features a full line of CBD-infused and topical products. After posting record sales earlier this year, this strategic push into the lucrative CBD market could propel the company to new records. Also quick to see the opportunity, Constellation Brands Inc. (NYSE: STZ) recently exercised warrants to purchase additional shares of Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED), increasing its stake in the Ontario cannabis producer to more than 38%. In a nod to the value of having CPG expertise, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has appointed Miguel Martin, an international CPG executive, as its chief commercial officer. And Charlotte’s Web Holdings Inc. (OTC: CWBHF) (TSX: CWEB) has announced a collaboration between its CW Labs science division and the University at Buffalo’s  Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program that provides a better understanding of the therapeutic uses and safety of cannabinoids.

On election day this year, four more states voted to legalize the recreational use of cannabis, bringing the total of states that now allow recreational cannabis use to 15. This growing acceptance of cannabis, and more specifically CBD, which is now legal in all 50 states, has sparked an explosion of new CBD-infused products and brands within the consumer packaged goods (“CPG”) space. Estimates about how large the legalized cannabis market may grow vary widely, but a Lido Consulting report notes that the total addressable cannabis market (“TAM”) could potentially hit $1 trillion in global economic impact by 2027. Seeing almost unlimited potential, companies are rushing to take advantage of the massive opportunity. Continuing its aggressive growth strategy, The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) (Profile) entered the CBD space with the launch of its A88CBD(TM) brand. Already nationally recognized for its premium bottled water and flavor-infused water,  Alkaline Water now features a full line of CBD-infused and topical products. After posting record sales earlier this year, this strategic push into the lucrative CBD market could propel the company to new records. Also quick to see the opportunity, Constellation Brands Inc. (NYSE: STZ) recently exercised warrants to purchase additional shares of Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED), increasing its stake in the Ontario cannabis producer to more than 38%. In a nod to the value of having CPG expertise, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has appointed Miguel Martin, an international CPG executive, as its chief commercial officer. And Charlotte’s Web Holdings Inc. (OTC: CWBHF) (TSX: CWEB) has announced a collaboration between its CW Labs science division and the University at Buffalo’s  Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program that provides a better understanding of the therapeutic uses and safety of cannabinoids.

From the coronavirus pandemic to nationwide public unrest, 2020 has been a year that has inspired re-imagining public safety as the country has poignantly witnessed the challenges faced by law enforcement and security services across all verticals. The answers to some of society’s greatest problems today are not to be found simply in man power; rather, many of the answers lie in technology, like that of Knightscope Inc. (Profile), which is designed to augment and improve existing security infrastructure. Silicon Valley-based Knightscope, with its lineup of fully autonomous security robots, aligns with companies such as Palantir Technologies Inc. Class A (NYSE: PLTR), Axon Enterprise Inc. (NASDAQ: AAXN), L3Harris Technologies Inc. (NYSE: LHX) and Velodyne Lidar Inc. (NASDAQ: VLDR), which all share a passion for solving an array of security and safety problems, as well as protecting life and data with next-generation technology.

Lithium demand has soared with the advent of electric vehicles, as severe supply shortages pose a serious threat to the long-term sustainability of the Battery Electric Vehicle (“BEV”) transportation sector. However, another viable option for cleaner, cheaper and more sustainable transportation exists. Instead of battery-powered electric cars, vehicles powered with hydrogen, the most abundant resource in the universe, may be the key to truly disrupting the auto industry. The world is rapidly shifting away from the dwindling resource of fossil fuels, and hydrogen is expected to play a crucial role in slashing emissions and finally achieving sustainability. Hydrogen-powered electric vehicles are already commercially available with a multitude of cars, trucks and buses  planned and in production. This tsunami of hydrogen-powered vehicles could turn the tide on dangerous emissions and usher in a new era of transportation — if they can be fueled. While there’s an abundance of hydrogen in the universe, there is a massive lack of hydrogen fueling stations, with less than 70 stations spread throughout the United States. The lack of hydrogen fueling stations is the primary impediment to rapid adaptation and presents an enormous opportunity. Recent developments at Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) (Profile) could rectify this shortfall and may create a powerful force in facilitating the rollout of hydrogen vehicles across the nation. Clean Power Capital is an investment holding company that recently acquired a 90% equity stake in PowerTap Hydrogen Fueling Corp., a patented on-site hydrogen fueling intellectual property and technology that already has 14 installations around the country in private and public facilities. Plug Power Inc. (NASDAQ: PLUG) is credited for creating the first commercially market for hydrogen fuel cell technology and is building the hydrogen economy as a leading provider of comprehensive hydrogen fuel cell turnkey solutions and recently raised $1 billion for hydrogen investments. Ballard Power Systems Inc. (NASDAQ: BLDP) intends to deliver fuel cell power for a sustainable planet with its zero-emission PEM fuel cells that are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, passenger cars and forklift trucks. Nikola Corporation (NASDAQ: NKLA) designs and will manufacture zero-emission battery-electric and hydrogen-electric vehicles, electric vehicle drivetrains, vehicle components, energy storage systems, and hydrogen station infrastructure. Hydrogen power goes beyond just transportation. FuelCell Energy Inc. (NASDAQ: FCEL) develops turnkey distributed power generation solutions, and operates and provides comprehensive services for the life of power plants for utilities and industry.

Lithium demand has soared with the advent of electric vehicles, as severe supply shortages pose a serious threat to the long-term sustainability of the Battery Electric Vehicle (“BEV”) transportation sector. However, another viable option for cleaner, cheaper and more sustainable transportation exists. Instead of battery-powered electric cars, vehicles powered with hydrogen, the most abundant resource in the universe, may be the key to truly disrupting the auto industry. The world is rapidly shifting away from the dwindling resource of fossil fuels, and hydrogen is expected to play a crucial role in slashing emissions and finally achieving sustainability. Hydrogen-powered electric vehicles are already commercially available with a multitude of cars, trucks and buses  planned and in production. This tsunami of hydrogen-powered vehicles could turn the tide on dangerous emissions and usher in a new era of transportation — if they can be fueled. While there’s an abundance of hydrogen in the universe, there is a massive lack of hydrogen fueling stations, with less than 70 stations spread throughout the United States. The lack of hydrogen fueling stations is the primary impediment to rapid adaptation and presents an enormous opportunity. Recent developments at Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) (Profile) could rectify this shortfall and may create a powerful force in facilitating the rollout of hydrogen vehicles across the nation. Clean Power Capital is an investment holding company that recently acquired a 90% equity stake in PowerTap Hydrogen Fueling Corp., a patented on-site hydrogen fueling intellectual property and technology that already has 14 installations around the country in private and public facilities. Plug Power Inc. (NASDAQ: PLUG) is credited for creating the first commercially market for hydrogen fuel cell technology and is building the hydrogen economy as a leading provider of comprehensive hydrogen fuel cell turnkey solutions and recently raised $1 billion for hydrogen investments. Ballard Power Systems Inc. (NASDAQ: BLDP) intends to deliver fuel cell power for a sustainable planet with its zero-emission PEM fuel cells that are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, passenger cars and forklift trucks. Nikola Corporation (NASDAQ: NKLA) designs and will manufacture zero-emission battery-electric and hydrogen-electric vehicles, electric vehicle drivetrains, vehicle components, energy storage systems, and hydrogen station infrastructure. Hydrogen power goes beyond just transportation. FuelCell Energy Inc. (NASDAQ: FCEL) develops turnkey distributed power generation solutions, and operates and provides comprehensive services for the life of power plants for utilities and industry.

From the coronavirus pandemic to nationwide public unrest, 2020 has been a year that has inspired re-imagining public safety as the country has poignantly witnessed the challenges faced by law enforcement and security services across all verticals. The answers to some of society’s greatest problems today are not to be found simply in man power; rather, many of the answers lie in technology, like that of Knightscope Inc. (Profile), which is designed to augment and improve existing security infrastructure. Silicon Valley-based Knightscope, with its lineup of fully autonomous security robots, aligns with companies such as Palantir Technologies Inc. Class A (NYSE: PLTR), Axon Enterprise Inc. (NASDAQ: AAXN), L3Harris Technologies Inc. (NYSE: LHX) and Velodyne Lidar Inc. (NASDAQ: VLDR), which all share a passion for solving an array of security and safety problems, as well as protecting life and data with next-generation technology.

CNS Pharmaceuticals (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has submitted an Investigational New Drug (“IND”) application, which has been accepted for review, to the U.S. Food and Drug Administration (“FDA”) for Berubicin in the treatment of Glioblastoma Multiforme (“GBM”). The Company plans to evaluate the efficacy of Berubicin in a Phase 2 Trial for adults with GBM who have failed first-line therapy and commence the trial within the first quarter of 2021, pending the FDA’s acceptance of the Company’s filing.

To view the original press release, visit https://nnw.fm/1Qib1

CNS Pharmaceuticals (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has submitted an Investigational New Drug (“IND”) application, which has been accepted for review, to the U.S. Food and Drug Administration (“FDA”) for Berubicin in the treatment of Glioblastoma Multiforme (“GBM”). The Company plans to evaluate the efficacy of Berubicin in a Phase 2 Trial for adults with GBM who have failed first-line therapy and commence the trial within the first quarter of 2021, pending the FDA’s acceptance of the Company’s filing.

To view the original press release, visit https://nnw.fm/1Qib1

Investors are flocking to gold, silver and other precious metals in record numbers. One firm, BullionVault, reports that in the past six months demand to invest in gold, silver and platinum has reached almost half a billion dollars. “Net of client selling, investing in physical bullion on our peer-to-peer platform — first opened in 2005 — has now topped $442 million since the pandemic reached Europe and North America in March,” the company said. Mining companies around the world are benefitting from this rising investment tide, as they work to strengthen their positions, increase their holdings and ultimately provide more raw material for investors looking for more stable options. One of those companies, GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) (GOH Profile), has secured options on some of the most promising properties in the highly productive Maricunga Gold Belt of Chile, including one yielding rock chip sample assays of 764 grams per tonne gold and 719 grams per tonne silver. GoldHaven plans to commence a drilling program in January 2021. Yamana Gold Inc. (NYSE: AUY) is expanding its footprint with its recent acquisition of Monarch properties in the Abitibi Region in Quebec, Canada. Other companies are releasing impressive reports regarding their current operations. Fosterville South Exploration Ltd (OTC: FSXLF) has provided high-grade assays of up to 152 grams per tonne gold in rock chip samples at the Star of the Glen target on the Golden Mountain project. Kinross Gold Corporation (NYSE: KGC) (TSX: K) announced the results of a prefeasibility study on its Lobo-Marte project, which indicates the potential of a cornerstone asset with attractive all-in sustaining costs to enhance the company’s long-term production profile. Gold Fields Limited American Depositary Shares (NYSE: GFI) is considering a number of automation projects at its South Deep gold mine in Gauteng, southwest of Johannesburg.

The surge in the price of gold has been well documented this year. The precious metal closed above $2,000 an ounce earlier this year, leading experts to forecast future prices from $2,300 (Goldman Sachs) to as high as $3,000 (Bank of America) in the coming months. In addition, copper prices have also risen to their highest levels in more than two years, climbing to more than $6,800 a ton. These numbers bode well for companies in the precious metals space, especially companies such as Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) (JOSE Profile), which has interests in both copper and gold. Earlier this month, JOSE released a feasibility study regarding its 100% owned Josemaria Copper-Gold Project in San Juan Province, Argentina. Other companies that are making moves in the base and precious metals sectors include Rio Tinto Plc (NYSE: RIO), which just announced that its Kennecott site in Utah is the first producer to be awarded the Copper Mark, the copper industry’s new independently assessed responsible production program. Freeport-McMoRan Inc. (NYSE: FCX) has commenced the Copper Mark process for six of its operating sites and has future plans to validate all of its operating sites against the program’s requirements. Southern Copper Corporation (NYSE: SCCO) recently released its Q3 2020 financial report, noting that its net sales totaled $2,129 million, up 14.5% compared to Q3 2019. Franco-Nevada Corporation (NYSE: FNV) also reported record revenue, EBITDA and net earnings in the third quarter with all material mining assets having returned to normal operations through the quarter.

The surge in the price of gold has been well documented this year. The precious metal closed above $2,000 an ounce earlier this year, leading experts to forecast future prices from $2,300 (Goldman Sachs) to as high as $3,000 (Bank of America) in the coming months. In addition, copper prices have also risen to their highest levels in more than two years, climbing to more than $6,800 a ton. These numbers bode well for companies in the precious metals space, especially companies such as Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) (JOSE Profile), which has interests in both copper and gold. Earlier this month, JOSE released a feasibility study regarding its 100% owned Josemaria Copper-Gold Project in San Juan Province, Argentina. Other companies that are making moves in the base and precious metals sectors include Rio Tinto Plc (NYSE: RIO), which just announced that its Kennecott site in Utah is the first producer to be awarded the Copper Mark, the copper industry’s new independently assessed responsible production program. Freeport-McMoRan Inc. (NYSE: FCX) has commenced the Copper Mark process for six of its operating sites and has future plans to validate all of its operating sites against the program’s requirements. Southern Copper Corporation (NYSE: SCCO) recently released its Q3 2020 financial report, noting that its net sales totaled $2,129 million, up 14.5% compared to Q3 2019. Franco-Nevada Corporation (NYSE: FNV) also reported record revenue, EBITDA and net earnings in the third quarter with all material mining assets having returned to normal operations through the quarter.

Investors are flocking to gold, silver and other precious metals in record numbers. One firm, BullionVault, reports that in the past six months demand to invest in gold, silver and platinum has reached almost half a billion dollars. “Net of client selling, investing in physical bullion on our peer-to-peer platform — first opened in 2005 — has now topped $442 million since the pandemic reached Europe and North America in March,” the company said. Mining companies around the world are benefitting from this rising investment tide, as they work to strengthen their positions, increase their holdings and ultimately provide more raw material for investors looking for more stable options. One of those companies, GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) (GOH Profile), has secured options on some of the most promising properties in the highly productive Maricunga Gold Belt of Chile, including one yielding rock chip sample assays of 764 grams per tonne gold and 719 grams per tonne silver. GoldHaven plans to commence a drilling program in January 2021. Yamana Gold Inc. (NYSE: AUY) is expanding its footprint with its recent acquisition of Monarch properties in the Abitibi Region in Quebec, Canada. Other companies are releasing impressive reports regarding their current operations. Fosterville South Exploration Ltd (OTC: FSXLF) has provided high-grade assays of up to 152 grams per tonne gold in rock chip samples at the Star of the Glen target on the Golden Mountain project. Kinross Gold Corporation (NYSE: KGC) (TSX: K) announced the results of a prefeasibility study on its Lobo-Marte project, which indicates the potential of a cornerstone asset with attractive all-in sustaining costs to enhance the company’s long-term production profile. Gold Fields Limited American Depositary Shares (NYSE: GFI) is considering a number of automation projects at its South Deep gold mine in Gauteng, southwest of Johannesburg.

Big pharma and life science companies are making big news these days. The drug-development space is seeing strong investor interest as these companies make breakthrough advancements that address vast unmet medical needs. Strategic M&A moves are adding spice to the gumbo for investors as pioneering research remains focused on providing life-changing treatments for those suffering from a myriad of disorders. One of the largest and trickiest medical disorders of mankind may be on the cusp of more effective treatment. Depression is often kept in the dark and not talked about, but it is estimated that more than 17 million adults in the United States experienced at least one major depressive episode in 2019 alone, while one out of every four people in the world struggle with a diagnosable mental disorder. Life sciences company Cybin Inc. (Cybin Profile) is at the vanguard of new therapeutic protocols that target these disorders. Cybin is intent on developing psychedelic therapeutics along with unique delivery mechanisms that target depression as well as other psychiatric and neurological conditions. The company could benefit from two game-changing announcements made in the past few days: the company just completed its previously announced reverse takeover and a groundbreaking study published in JAMA Psychiatry reports that in a recent study a treatment featuring psilocybin actually worked better than typical antidepressant medications. Other drug-development companies are experiencing similar milestone moments. Last month Praxis Precision Medicines Inc. (NASDAQ: PRAX) closed on its upsized initial public offering of 11,500,000 shares of common stock, resulting in aggregate gross proceeds to Praxis of $218.5 million. Earlier this year, AbbVie Inc. (NYSE: ABBV) completed a transformative acquisition of Allergan. Less than a year ago, Axsome Therapeutics (NASDAQ: AXSM) realized more than $200 million when it closed on its public offering. And this summer Relmada Therapeutics Inc. (NASDAQ: RLMD) uplisted to trade on the Nasdaq Global Select Market.